Godshalk Welsh Capital Management Inc. Makes New Investment in Cigna Group $CI

Godshalk Welsh Capital Management Inc. bought a new position in Cigna Group (NYSE:CI) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,655 shares of the health services provider’s stock, valued at approximately $708,000.

Other institutional investors have also recently made changes to their positions in the company. Assetmark Inc. raised its position in Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after buying an additional 5,963 shares during the last quarter. apricus wealth LLC lifted its stake in Cigna Group by 715.9% during the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after acquiring an additional 8,340 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Cigna Group by 4.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 95,023 shares of the health services provider’s stock valued at $27,068,000 after acquiring an additional 4,394 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Cigna Group by 3.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock worth $29,046,000 after acquiring an additional 3,814 shares during the period. Finally, OFI Invest Asset Management grew its stake in shares of Cigna Group by 8,357.8% in the fourth quarter. OFI Invest Asset Management now owns 33,070 shares of the health services provider’s stock worth $9,102,000 after acquiring an additional 32,679 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 1.8%

Shares of CI stock opened at $285.29 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $75.47 billion, a price-to-earnings ratio of 12.09, a PEG ratio of 1.12 and a beta of 0.29. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The firm has a fifty day moving average price of $286.11 and a 200-day moving average price of $280.66.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Insider Transactions at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CI shares. Royal Bank Of Canada increased their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Guggenheim lifted their price objective on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Finally, Jefferies Financial Group cut their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.